InvestorsHub Logo

SeeingGreen420

02/25/17 4:37 PM

#28103 RE: ebota12 #28099

That is an ignorant statement IMHO, as I've stated, if you do have shares in this company, please sell so I can have them. Thanks and have a nice day.

GreenBrickRoad

02/25/17 5:39 PM

#28104 RE: ebota12 #28099

ebota, how much have you really looked into this? I'm just curious if you're familiar with microbial and cannabinoid testing? I really would like to hear more about the feasibility (or unlikelihood) of ATTBF ever posting 7 figure revenue numbers from NV at some point in their future. From what I've found online, the cost of a single sample exceeds $100, sometimes even closer to $200, especially if you require expedited services. And although the market will take time to grow, eventually licensed producers may have dozens of samples to test on a very regular basis. At least, it sounds like HC will require very regular testing, from the final report of the Task Force on Cannabis Legalization and Regulation submitted in Nov 2016.

GreenReality

02/26/17 12:12 PM

#28109 RE: ebota12 #28099

Testing will be a keystone on the new regulation. Goodbye random dispensaries with mold and rat shit in your random street 'medical' pot, it's been a slice. Most won't know how to read the new regulations, will try to interpret the rules a la carte and be cited and shut down, swear up and down to their friends that it's just not fair and simply not get it.

ebota12

02/28/17 10:07 AM

#28167 RE: ebota12 #28099

I forgot one more very important thing here: Abattis only owns 75% of Northern Vine! So reduce those projections by 25%.

Seems Experion may have a decent management team because the only topics making progress have their hands in it. Abattis' wholly owned subs are just issuing PR's about "potential" markets ... FOUR YEARS RUNNING!

ebota12

10/27/17 10:13 AM

#30527 RE: ebota12 #28099

Does anyone have intelligent, quantitative data to dispute any of these figures about testing? Interested in hearing some intelligent, fact based DD.

I'm starting to think this was a good move, to sell majority of the lab. I'm a huge skeptic of just running a test lab with our share structure. I believe extraction (medicine?) is the only way to significantly move up from here. I would rather have another company with competent management drive this bus and receive 47% of the benefit, than to receive 100% of much less revenue. Getting large quantities of cheap biomass for extraction seems to be a good move, but I think we are a year away from any legitimate SP appreciation.